Drug profile · INN
cytarabine
DEPOCYTE
- US status
- approved
- Patents linked
- 0
- News articles
- 0
Quick answer
cytarabine (DEPOCYTE) is an FDA-listed pharmaceutical active ingredient. Associated with Pacira Ireland Limited. Route of administration: injection. Current US regulatory status: approved.
Key facts
INN cytarabine
Brand DEPOCYTE
Route INJECTION
Formulation INJECTABLE, LIPOSOMAL
ATC code L01BC01
Originator Pacira Ireland Limited
Frequently asked questions
What is cytarabine?
cytarabine (DEPOCYTE) is an FDA-listed pharmaceutical active ingredient. Associated with Pacira Ireland Limited. Route of administration: injection. Current US regulatory status: approved.
What is the brand name for cytarabine?
DEPOCYTE is a marketed brand name for cytarabine. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of cytarabine?
cytarabine has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.